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Effect of Dietary Counseling on a Comprehensive Metabolic Profile from
Childhood to Adulthood
Miia Lehtovirta, MD1, Katja Pahkala, PhD1, Harri Niinikoski, MD, PhD2, Antti J. Kangas, Msc(Tech)3, Pasi Soininen, PhD3,
Hanna Lagström, PhD4, Jorma S. A. Viikari, MD, PhD5, Tapani Rönnemaa, MD, PhD5, Antti Jula, MD, PhD6,
Mika Ala-Korpela, PhD3,7,8,9,10,11, Peter Würtz, PhD3,*, and Olli T. Raitakari, MD, PhD1,12,*
Objectives To study the effects of repeated, infancy-onset dietary counseling on a detailed metabolic profile. Effects
of dietary saturated fat replacement on circulating concentrations of metabolic biomarkers still remain unknown.
Study design The Special Turku Coronary Risk Factor Intervention Project (STRIP) study is a longitudinal, ran-
domized atherosclerosis prevention trial in which repeated dietary counseling aimed at reducing the proportion of
saturated fat intake. Nuclear magnetic resonance metabolomics quantified circulating metabolites from serum samples
assessed at age 9 (n = 554), 11 (n = 553), 13 (n = 508), 15 (n = 517), 17 (n = 457), and 19 (n = 417) years.
Results The intervention reduced dietary intake of saturated fat (mean difference in daily percentage of total energy
intake: −2.1 [95% CI −1.9 to −2.3]) and increased intake of polyunsaturated fat (0.6 [0.5-0.7]). The dietary counseling
intervention led to greater serum proportions of polyunsaturated fatty acids (P < .001), with greater proportions of
both circulating omega-3 (P = .02) and omega-6 (P < .001) fatty acids. The proportion of saturated fatty acids in
serum was lower for both boys and girls in the intervention group (P < .001), whereas the serum proportion of mono-
unsaturated fat was lower for boys in the intervention group only (P < .001). The intervention also reduced circu-
lating intermediate-density lipoprotein and low-density lipoprotein lipid concentrations (P < .01). Dietary intervention
effects on nonlipid biomarkers were minor except from greater concentrations of glutamine in the intervention group.
Conclusions Repeated dietary counseling from infancy to early adulthood yielded favorable effects on multiple
circulating fatty acids and lipoprotein subclass lipids, particularly in boys. These molecular effects substantiate the
beneficial role of saturated fat replacement on the metabolic risk profile.
(J Pediatr 2017;■■:■■-■■).
Trial registration ClinicalTrials.gov: NCT00223600.
T he development of atherosclerosis is a lifelong process that starts in child-hood and leads to cardiovascular complications in later life.1-3 Efforts toprevent atherosclerosis at an early age are therefore justified to inhibit the
establishment of cardiovascular risk factors. Central to this primordial preven-
tion is a prudent diet aimed to prevent the development of adverse lipid levels,
excess adiposity, and elevated blood pressure.4,5
The Special Turku Coronary Risk Factor Intervention Project (STRIP,
ClinicalTrials.gov: NCT00223600) was conducted to study the effect of dietary in-
tervention initiated in infancy and maintained until the age of 20 years on
cardiometabolic risk factors.6 It is the only randomized trial examining the health
effects of reduced saturated fat diet in healthy individuals from infancy to young
adulthood.1,6 The intervention comprised repeated, individualized dietary coun-
seling with a main focus on replacing intake of saturated fat with unsaturated fat.
BMI Body mass index
E% Percentage of total energy intake
HDL High-density lipoprotein
HDL-C High-density lipoprotein cholesterol
IDL Intermediate-density lipoprotein
LDL Low-density lipoprotein
LDL-C Low-density lipoprotein cholesterol
MUFA Monounsaturated fatty acids
NMR Nuclear magnetic resonance
PUFA Polyunsaturated fatty acids
SAFA Saturated fatty acids
STRIP The Special Turku Coronary Risk Factor Intervention Project
VLDL Very low-density lipoprotein
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We have shown previously that the intervention is effective in
decreasing saturated fat intake and leads to lower serum low-
density lipoprotein cholesterol (LDL-C) concentration from
infancy until 19 years of age.7 In addition, the intervention has
been associated with improved insulin sensitivity,8 lower blood
pressure,9 enhanced brachial artery endothelial function,2 in-
creased ideal cardiovascular health score,10 and reduced risk
for the metabolic syndrome.11 What is currently not well un-
derstood is the influence of reduced saturated fat intake on cir-
culating levels of fatty acids and lipoprotein subclass measures.
The dietary counseling also potentially could affect even
nonlipid metabolites, such as amino acid levels and other
emerging metabolic biomarkers for the risk of cardiometabolic
diseases.12
The present study was undertaken to assess the effects of the
dietary-counseling intervention on a detailed serum meta-
bolic profile. High-throughput nuclear magnetic resonance
(NMR) metabolomics provides simultaneous quantification
of circulating metabolites, including fatty acids, amino acids,
and detailed lipoprotein subclass profiling. This methodol-
ogy has uncovered and validated novel fatty acid and nonlipid
biomarkers for the risk of cardiovascular disease and type 2
diabetes.12-16 The detailed metabolic profiling can further
provide increased molecular understanding of the pathophysi-
ology of atherosclerosis and underlying risk factors.17-20 Here,
we investigated the effects of the randomized STRIP dietary
intervention trial on a comprehensive serummetabolic profile
measured at 6 time points at ages 9, 11, 13, 15, 17, and 19 years
in 554 participants.
Methods
The STRIP study is a prospective, randomized, infancy-onset
intervention trial aiming to reduce the risk of atherosclerosis.6,7,11
The families of 5-month-old infants were recruited to the study
from well-baby clinics in Turku, Finland, between February
1990 and June 1992.When the infants were 6 months old, their
families received detailed information about STRIP, and a total
of 1062 infants (56.5% of the eligible age cohort) then em-
barked on the study (Figure 1; available at www.jpeds.com).
At the age of 7 months, they were allocated randomly to a
dietary intervention group (N = 540; 256 girls) or a control
group (N = 522; 256 girls). Both groups met with a nutrition-
ist and a pediatrician or a nurse during their study visits.
The intervention group received individualized dietary coun-
seling at 1- to 3-month intervals until the child was 2 years
of age and biannually thereafter until 20 years of age.6,11,21 The
children in the control group received only basic health edu-
cation routinely given at Finnish well-baby clinics and by school
health care. The control group was met biannually until 7 years
of age and annually thereafter until 20 years of age.
For the present analysis, data were available from 6 time
points with metabolic biomarkers quantified by high-
throughput NMR metabolomics from serum samples drawn
at age 9 (n = 554), 11 (n = 553), 13 (n = 508), 15 (n = 517), 17
(n = 457), and 19 (n = 417) years. This represents 92%-99%
of total number of study participants. This kind of an intense
intervention trial spanning over 2 decades inevitably has a sub-
stantial loss to follow-up. No systematic differences have been
found between the study participants and those lost to follow-
up in key characteristics, such as weight, total cholesterol, blood
pressure, or saturated fat intake.2,6,11 The study was approved
by the Joint Commission on Ethics of the Turku University
and the Turku University Central Hospital. Written in-
formed consent was obtained from the parents in the begin-
ning of the study and from the adolescents at 15 and 18 years
of age.
Dietary Counseling and Food Records
The individualized dietary counseling was designed to meet
the Nordic Dietary Recommendations.22,23 The main aim was
to replace saturated fat with unsaturated fat in the diet without
reducing the total fat intake. The intervention aimed at fat intake
of 30%-35% of daily energy (E%, or percentage of total energy
intake), unsaturated to saturated fatty acid (SAFA) ratio of 2:1,
and cholesterol intake of <200 mg/d. A fixed diet was never
ordered but instead changes in the diet were suggested based
on the child’s food records (eg, replacement of dairy fat–
blend spreads with vegetable oil–based spreads).
In the beginning of the intervention trial, breast feeding or
formula was advised until 1 year of age, and after that, 0.5-
0.6 L of skimmed milk daily was recommended for the inter-
vention children. The intervention families were advised to add
2-3 teaspoonfuls of soft margarine or vegetable oil to the child’s
diet daily from 12 to 24 months of age. Quality of dietary fat
was a major topic of the counseling throughout childhood and
adolescence but the use of vegetables, fruits, and low-salt and
whole-grain products also was recommended.11,24 In terms of
protein, specific counseling related to plant- or animal-based
sources was not given. The counseling was given to the parents
until the child was 7 years of age, and from then onward, gradu-
ally more information was given directly to the child. Most of
the counseling material used, eg, brochures and paper-pencil
tasks, was especially developed for the project due to the lack
of ready-made materials for children. The parents were in-
formed about the contents of the child’s counseling sessions
and encouraged to discuss the topics with the child at home.
All families (parents, caregivers) and school staff kept food
records of the child’s food intake. A 3-day food record was ob-
tained every 6 months until the age of 2 years and after that,
a 4-day food record was used to account for greater variation
in the diet. After 7 years, the intervention children continued
to keep food records biannually, and the control children kept
them annually. Food records were kept for consecutive days,
and they included at least 1 weekend day. During follow-up
visits, the nutritionist reviewed the food records for complete-
ness and accuracy. Nutrient intakes were analyzed with a Micro
Nutrica program, developed by the Research and Development
Centre of the Social Insurance Institution, Turku, Finland.25
The data bank of the program is flexible, permitting continu-
ous updating and additions of new single or composite foods.
Lipid and Metabolite Quantification
A high-throughput NMRmetabolomics platform was used for
quantification of 60 serum lipid and metabolite measures
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(Table I; available at www.jpeds.com). This platform pro-
vides measurement of routine lipids, lipid concentrations of
14 lipoprotein subclasses and major subfractions, and further
quantifies abundant fatty acids, amino acids, ketone bodies,
and gluconeogenesis-related metabolites in absolute concen-
tration units.13 The metabolic profiling was measured from
fasting serum samples from 6 time points collected when the
study participants were aged 9-19 years (Table II; available at
www.jpeds.com). The NMR metabolomics platform recently
has been used in various epidemiologic studies20,26,27 and details
of the experimentation have been described.13,28
Statistical Analyses
Metabolic measures with skewed distributions were log(x+1)-
transformed before analyses.Analyses were conducted both sex-
combined and stratified by sex because the STRIP study has
previously reported pronounced sex interactions in the lipid-
lowering effects of the intervention.7 For each measure of
metabolite concentrations or dietary intake, a linear mixed-
effects model for repeated measures was fitted with the inter-
vention group, sex and age as fixed effects and subject as a
random effect. Analysis with study group×sex interaction in-
cluded in the model also were performed. To facilitate com-
parison of effect sizes across metabolites, all metabolic measures
were scaled to SD units. The effect sizes of the intervention
reported hereby correspond to the average difference in SD-
scaled metabolite concentration due to the intervention.
Age×study group interaction was included in all dietary intake
analyses. Statistical analyses were conducted with R 3.2 soft-
ware (R Foundation for Statistical Computing, Vienna,
Austria).29
Results
This study investigated the effect of a randomized, infancy-
onset dietary intervention on the circulating metabolic profile
of 417-554 participants assessed at 6 time points between 9
and 19 years of age. Clinical characteristics of the study par-
ticipants are shown in Table II.
Intervention Effects on Dietary Fat Intake
Dietary intake of different fatty acid types for boys and girls
in the intervention and control groups is shown in Figure 2.
Children in the intervention group had lower saturated fat
intake compared with control children throughout the inter-
vention.However, the difference of approximately 3 E% in early
childhood decreased toward the end of the intervention at
20 years of age (mean difference in daily E% between groups:
−2.0 [95% CI −1.7 to −2.3] in boys and −1.8 [−1.5 to −2.1]
in girls). The intervention also resulted in greater intakes of
polyunsaturated fatty acids (PUFA) for both sexes (mean daily
difference in E% 0.5 [0.4-0.6] for boys and 0.6 [0.5-0.8] for
girls), but this difference decreased toward adolescence. Con-
sequently, the intervention children had a greater ratio of un-
saturated to saturated fat in their diet compared with control
children throughout the intervention. For both boys and girls,
no consistent differences were observed in the dietary intake
of monounsaturated fatty acids (MUFAs).
Intervention Effects on Serum Metabolic Profile
The effects of the dietary intervention on circulating meta-
bolic profile are illustrated separately for boys and girls in
Figures 3-5. Overall, the metabolic effects of the interven-
tion tended to be stronger in boys than in girls but generally
following a similar pattern in both sexes.All differences between
the intervention group and controls are shown in SD-scaled
concentration units to enable comparison across the meta-
bolic measures. The corresponding differences in absolute con-
centrations are listed in Table I.
Serum Fatty Acids. The most prominent differences between
the intervention group and the control group were observed
in circulating fatty acids (Figure 3). In boys, the serum pro-
portion of PUFA, relative to total fatty acids, was greater in
the intervention group compared with the control group (0.30
SD [0.14-0.40], corresponding to 1.0% [0.53-1.49] greater PUFA
ratio). Greater serum proportions were observed for both PUFA
omega-3 and omega-6 fatty acids, but the effects tended to be
stronger for omega-6. Similar effects were observed for themain
constituents of these PUFAs, namely docosahexaenoic acid (an
omega-3 fatty acid) and linoleic acid (an omega-6 fatty acid).
In contrast, the serum MUFA proportion was lower among
the intervention group compared with controls. In girls, the
difference in PUFA proportion between the intervention and
control groups were weaker than in boys, but the association
pattern was similar, which is reflected as a strong combined
analysis result. There was a significant sex interaction for the
proportion of MUFA and docosahexaenoic acid. The propor-
tion of serum SAFAs was significantly lower in the interven-
tion group compared with the control group.
Lipoprotein Lipids. The dietary intervention effects on a de-
tailed panel of lipoprotein lipidmeasures are shown in Figure 4.
The intervention effects on the routine lipid measures, eg,
LDL-C, are shown to facilitate interpretation and put the as-
sociation magnitudes into perspective.We have shown that the
repeated dietary counseling given in the STRIP study is asso-
ciated with decreased LDL-C concentrations in both boys and
girls.7 In the present study, the levels of total cholesterol, non–
high-density lipoprotein cholesterol (HDL-C), and LDL-C were
reduced for both sexes, whereas the concentrations of triglyc-
erides and apolipoprotein B were reduced for the interven-
tion boys only. No differences were found between the
concentrations of HDL-C and apolipoprotein A-I between the
study groups. The current analyses of lipoprotein subclasses
were undertaken to provide more insight into the detailed lipid
effects of the intervention.Overall, the lipoprotein subclass pro-
filing showed reduced lipid concentrations (ie, combined con-
centration of cholesterol, phospholipid, and triglycerides) in
the very low-density lipoprotein (VLDL) particles in the in-
tervention boys and reduced lipid concentrations in the
intermediate-density lipoprotein (IDL) and LDL subclasses in
the intervention group. In the intervention boys, the lipid con-
centrations in VLDL particles were significantly lower, in par-
ticular for medium-sized VLDL (−0.24 SD [−0.39 to −0.09])
and small VLDL (−0.27 SD [−0.42 to −0.12]). Accordingly, the
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levels of remnant-cholesterol (=VLDL cholesterol + IDL cho-
lesterol) were lower for boys in the intervention group. Also,
VLDL particle size was smaller for boys in the intervention
group. No effects for VLDL lipids were observed for girls. There
were no differences found in serum triglycerides between the
girls in the intervention group and the girls in the control group,
and this might be reflected in VLDL particles because triglyc-
erides are their main constituents. For both sexes, no robust
differences were observed in the lipid concentration of HDL
subclasses, although a tendency of lower lipid concentration
of small HDL particles was evident in the intervention boys
compared with controls.
Nonlipid Metabolites. The intervention effects on nonlipid
metabolic biomarkers were modest and broadly similar for boys
and girls (Figure 5). The most robust metabolic effect was
found for greater levels of glutamine in the intervention group
compared with the control children. Furthermore, boys in the
intervention group also had lower serum levels of glycerol and
a tendency toward lower levels of branched-chain amino acids
and glycoprotein acetyls, an inflammatory biomarker,30 than
the boys in the control group.
Discussion
Repeated dietary counseling on low saturated fat intake from
infancy to early adulthood yielded favorable metabolic effects
on multiple circulating fatty acids that are predictive of car-
diovascular event risk and type 2 diabetes. The greater dietary
intake of PUFA in the intervention group resulted in greater
blood proportion of both serum omega-3 and omega-6 PUFAs.
The intervention group had lower dietary intake of SAFA, and
the circulating SAFA proportion also was reduced in the in-
tervention group. In contrast to dietary intake, the MUFA pro-
portion was decreased in intervention boys.All these differences
in the serum fatty acid balance are consistent with a less risk-
prone profile for cardiovascular diseases and type 2
diabetes.13,14,16 These results extend previous findings from the
STRIP study demonstrating lowering of serum LDL-C in the
intervention group7—a conclusion further corroborated here
by lipoprotein subclass profiling and extended also to VLDL
and IDL cholesterol. The intervention had limited effects on
nonlipid metabolites, with increased levels of glutamine as the
only robust exception. The overall molecular effects assessed
at 6 time points in a long-running dietary intervention trial
Figure 2. Dietary intake of fatty acids in the intervention and control groups of boys and girls. Values are mean (SE) dietary
intake in energy percentage of saturated, monounsaturated, and polyunsaturated fatty acids from age 1 to 20 years. The dietary
intake is also shown for the sum of MUFA + PUFA relative to SAFA.
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substantiate the beneficial role of replacing SAFA intake on the
detailed metabolic risk profile.
Dietary guidelines recommend the reduction of SAFA intake
to lower the risk of cardiovascular diseases.31,32 Unsaturated fats
are the preferred replacement nutrient, especially PUFAs. Ac-
cordingly, the intervention reduced the dietary intake of SAFA
and increased the intake of PUFA in both sexes. Many obser-
vational studies have linked greater circulating levels of omega-3
fatty acids with reduced cardiovascular disease risk.14,33 However,
clinical trial evidence is unsupportive on benefits of omega-3
fatty acid supplementation.34,35 Novel reports in large prospec-
tive cohorts14,36 have strengthened the evidence that greater
levels of circulating omega-6 PUFAs predict reduced cardio-
vascular risk; however, causality remains unclear. Serum levels
of MUFA are rarely measured in large studies, but a recent
meta-analysis of 3 prospective studies demonstrated adverse
cardiovascular risk association for greater MUFA, and the
MUFA to be as strong biomarker as LDL-C.14 Whereas this
might be considered to contrast dietary recommendations on
the benefit in MUFA intake, the present study demonstrates
that dietaryMUFA intake and circulating serum levels of MUFA
do not follow a similar pattern. Although we cannot separate
whether the decrease in MUFA ratio observed for interven-
tion boys is a result of increased PUFA intake or decreased SAFA
intake, we speculate that lower serum proportion of MUFA
is primarily due to decreased SAFA intake, because desaturation
from SAFA is a primary source for serum MUFAs.26 It is also
reported that dietary SAFA and MUFA intakes correlate in
Western countries.37,38
The STRIP study previously has shown that the dietary in-
tervention leads to reduction in serum total and LDL-C, as well
as triglycerides and apolipoprotein B in boys from infancy until
19 years of age.7 The difference in LDL-C also was seen in girls
when analyzed between the ages of 5 and 19 years.7,39 In the
present analysis, we examined the differences in the meta-
bolic profile between the study groups in 6 time points. The
benefits of the intervention are substantiated by our results on
the more detailed lipoprotein subclass patterns, with reduced
lipid concentrations in LDL and IDL particles for both sexes
and in the boys in the intervention group also in the small
and medium-sized VLDL. These VLDL lipoprotein particles
are the main carriers of cholesterol in the VLDL fraction and
may be small enough to penetrate the arterial wall to cause
atherosclerosis.40 Consistent with these results, the choles-
terol carried by VLDL and IDL particles, ie, remnant choles-
terol, was lower in the boys in the intervention group compared
with the control boys. Evidence in humans shows that remnant
cholesterol may have a causal role in development of athero-
sclerosis and the risk for ischemic heart disease.40 In line with
our results, an intervention study targeting the intake of whole
grains, fish, and bilberries in adults with impaired glucose me-
tabolism found changes in lipid metabolites, eg, increased
concentration of large high-density lipoprotein particle
(L-HDL) particles.19
Many nonlipid metabolites, such as amino acids, are emerg-
ing biomarkers for the risk of cardiovascular disease and type
2 diabetes; however, the underlying mechanisms are still largely
unclear.12,14,26 For instance, greater serum glutamine levels are
predictive of lower risk for type 2 diabetes.41 Glutamine also
has been associated inversely with cardiovascular disease risk.14
Branched-chain amino acids, including isoleucine, are asso-
ciated with insulin resistance and risk for type 2 diabetes.16,41
Figure 3. Differences in circulating fatty acid ratios between the intervention group and the control group. Effect estimates are
SD-scaled differences between boys in the intervention group with respect to boys in the control group (blue) and girls in the
intervention group with respect to girls in the control group (red). Error bars indicate 95% CIs. P values for sex-combined analy-
sis are shown in case there were no statistically significant study group×sex interaction. Metabolic measures are from pooled
analyses across the 6 time points. DHA, docosahexaenoic acid; LA, linoleic acid; u-3 fatty acids/total fatty acids, ratio of omega-3
fatty acids to total fatty acids.
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Although the intervention effect on these nonlipid metabolites
was mostly weak, the metabolic differences were in the direc-
tion of lower cardiometabolic risk, especially for boys in the
intervention group. We have shown previously that serum
insulin is lower in both boys and girls in the intervention group.
However, there were only minor effects on the gluconeogenesis-
related metabolites, albeit a tendency for lower concentra-
tions for boys in the intervention group were observed.
To make the reported metabolic differences more con-
crete, it is worthwhile to compare the results to recently reported
causal effects of body mass index (BMI) on metabolic profile
in young adults.18 For instance, the dietary intervention re-
sulted in 0.30 SD greater serum proportion of omega-6 fatty
acid, ie, ratio of omega-6 fatty acids concentration to total fatty
acid concentration, for boys and 0.15 SD greater for girls—
this effect is similar to the causal effect of ≈7 lower BMI units
(kg/m2) for boys and ≈3 lower BMI units for girls. Similarly,
the effect of the intervention on LDL-C corresponds to the
causal effect of ≈2 units lower BMI for both sexes. Although
we acknowledge that adiposity has wider metabolic effects than
Figure 4. Differences in serum lipid measures between the intervention group and the control group. Effect estimates are SD-
scaled differences between boys in the intervention group with respect to boys in the control group (blue) and girls in the in-
tervention group with respect to girls in the control group (red). Error bars indicate 95% CIs. P values for sex-combined analysis
are shown in case there were no statistically significant study group×sex interaction. Lipid measures are from pooled analysis
across the 6 time points, and those with skewed distributions were log(x+1)-transformed before analyses. C, cholesterol;
L, large, M, medium; S, small; XL, very large; XS, very small; XXL, extremely large.
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the dietary effects observed here,18 these comparisons
nevertheless give perspective to the notable magnitude of the
metabolic effects of the intervention.
Overall, the effect of the dietary intervention on the meta-
bolic profile was more prominent in boys than in girls, even
though the differences in dietary intakes of fatty acids were
similar in both sexes. The sex difference is most evident in tri-
glycerides and reflected in the lipid concentrations of VLDL
particles. This discrepancy in serum lipids has been reported
in our previous studies and the reasons are still unknown.7,39,42
Differences in body composition, a more pronounced inter-
vention effect on consumption of favored/unfavored foods in
boys, and sex hormone levels may have an impact on this
outcome.
The strengths and limitations of the study should be con-
sidered. The STRIP trial is unique worldwide, as no other study
has introduced dietary counseling in infancy and continued
it for 20 years.However, the long-term intervention study design
limits options for comparison to similar studies and replica-
tion. Nevertheless, the observed effects of dietary intake and
corresponding circulating fatty acid differences are sup-
ported by observational cohorts.14 Strengths of the study include
detailed metabolic profiling of a large number of partici-
pants repeated at up to 6 time points studied, which allowed
us to uncover molecular effects of the intervention across many
established and emerging metabolic biomarkers. Limitations
include potential selection bias during the initial recruit-
ment phase as the participating families might have been more
Figure 5. Differences in circulating metabolites between the intervention group and the control group. Effect estimates are SD-
scaled differences between boys in the intervention group with respect to boys in the control group (blue) and girls in the in-
tervention group with respect to girls in the control group (red). Error bars indicate 95% CIs. P values for sex-combined analysis
are shown in case there were no statistically significant study group×sex interaction. Metabolic measures are from pooled analy-
ses across the 6 time points, and those with skewed distributions were log(x+1)-transformed before analyses.
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interested in health-related matters. The intervention effect
might also have been diluted because the control children and
their families regularly received information regarding, for
example, their serum cholesterol levels. This kind of an inter-
vention trial spanning over 2 decades inevitably has a sub-
stantial loss to follow-up. The most common reasons for
discontinuance were moving away from the area, at young age
child’s recurring infections, and reluctance to blood sampling.6
No systematic differences have been found between the study
participants and those lost to follow-up in key characteris-
tics, such as weight, total cholesterol, blood pressure, or satu-
rated fat intake.2,6,11 Therefore, our results were unlikely
influenced by systematic selection bias.A limitation of the study
is also that we do not have hormonal or body composition data
to allow detailed analyses into the sex differences. The dietary
intervention in the STRIP study had prominent metabolic
effects on serum of fatty acid balance, in concordance with
dietary SAFA replacement, which led to greater intake of PUFA.
The proportions of serum omega-3 and omega-6 fatty acids
were greater in the intervention group compared with the
control group. The proportion of circulating MUFA was lower
in the intervention group, partly contrasting the dietary intake.
However, the circulating fatty acid differences were in line with
lower cardiovascular disease risk and type 2 diabetes risk. This
was especially seen in boys, whereas metabolic effects in girls
were less prominent. The levels of total cholesterol, non–HDL-
C, and LDL-C were reduced in the intervention group for both
sexes. Boys also displayed favorable lowering of triglycerides
and triglyceride-rich lipoprotein subclasses in the interven-
tion group. These results emphasize the value of detailed meta-
bolic profiling to assess the molecular effects of dietary
supplementation or counseling.43 The circulating metabolic
biomarkers might serve as better markers of long-term dietary
quality and could present as molecular intermediates to bridge
the intricate relation between dietary fat and cardiovascular
risk. To conclude, the STRIP dietary intervention resulting in
lower saturated fat intake was favorably reflected in multiple
serum fatty acids and lipoprotein subclasses through child-
hood to young adulthood. Future follow-ups will show whether
these changes lead to lower cardiovascular event risk. ■
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1880 infants aged 5 months and their families
from Turku city well-baby clinics, 1990-1992
1105 infants aged 6 months 
Detailed information about the trial at the 
Research Centre of Applied and Preventive
Cardiovascular Medicine
1062 infants aged 7 months 
randomized
Intervention group 
n = 540
Follow-up
Visits, food records, and blood 
samples at least annually 
beginning at age 7 months
Control group 
n = 522
Follow-up
Visits, food records, and blood 
samples at least annually 
beginning at age 7 months
At age 20 years 
n = 201
At age 20 years 
n = 249
Figure 1. Flowchart of the STRIP study.
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Table I. Mean (SD)metabolite concentrations and effect estimates for all metabolic measures analyzed in absolute con-
centration units
Metabolite measures
Girls
Mean (SD)
Boys
Mean (SD)
Girls effect
estimate, beta
Boys effect
estimate, beta
Omega-3 fatty acids, % 4.21 (0.91) 4.12 (0.84) 0.05240 0.16700
Omega-6 fatty acids, % 34.05 (3.22) 34.09 (3.36) 0.37900 0.96900
PUFA, % 38.44 (3.68) 38.29 (3.80) 0.44400 1.01000
MUFA, % 23.84 (2.69) 23.62 (2.91) −0.11300 −0.78100
SAFA, % 37.90 (2.45) 38.17 (2.57) −0.33700 −0.34700
Docosahexaenoic acid, % 1.72 (0.65) 1.55 (0.55) −0.00971 0.09660
Linoleic acid, % 27.44 (3.27) 27.34 (3.41) 0.61900 0.93100
Total fatty acids, mmol/L 9.19 (1.99) 8.56 (1.97) −0.13400 −0.30800
Degree of unsaturation 1.19 (0.07) 1.18 (0.06) 0.00348 0.01550
Total cholesterol, mmol/L 3.93 (0.87) 3.64 (0.82) −0.12300 −0.11400
Non–HDL-C, mmol/L 2.53 (0.79) 2.32 (0.75) −0.11900 −0.13500
Total triglycerides, mmol/L 0.84 (0.35) 0.77 (0.34) 0.01110 −0.08600
LDL-C, mmol/L 1.37 (0.45) 1.24 (0.42) −0.07060 −0.06950
HDL-C, mmol/L 1.41 (0.27) 1.32 (0.29) −0.00378 0.01810
Apolipoprotein B, g/L 0.74 (0.15) 0.70 (0.15) −0.02100 −0.03530
Apolipoprotein A-1, g/L 1.44 (0.18) 1.37 (0.17) −0.00414 0.00237
log extremely large VLDL, mmol/L 0.02 (0.02) 0.02 (0.02) −0.00103 −0.00279
log very large VLDL, mmol/L 0.03 (0.04) 0.03 (0.04) −0.00128 −0.00740
log large VLDL, mmol/L 0.12 (0.10) 0.12 (0.11) 0.00189 −0.02670
log medium VLDL, mmol/L 0.30 (0.12) 0.29 (0.13) 0.00260 −0.03030
log small VLDL, mmol/L 0.33 (0.10) 0.31 (0.09) 0.00562 −0.02560
Very small VLDL, mmol/L 0.41 (0.11) 0.38 (0.11) −0.00689 −0.02450
IDL, mmol/L 0.97 (0.27) 0.89 (0.25) −0.04590 −0.04020
Large LDL, mmol/L 1.08 (0.31) 0.98 (0.29) −0.05050 −0.05170
Medium LDL, mmol/L 0.59 (0.18) 0.54 (0.17) −0.02260 −0.03210
Small LDL, mmol/L 0.38 (0.11) 0.35 (0.10) −0.01610 −0.01980
log very large HDL, mmol/L 0.41 (0.12) 0.37 (0.14) −0.00996 0.01030
Large HDL, mmol/L 0.78 (0.26) 0.69 (0.28) 0.00746 0.03350
Medium HDL, mmol/L 0.78 (0.17) 0.74 (0.14) 0.00512 −0.00661
Small HDL, mmol/L 0.98 (0.13) 0.96 (0.11) 0.00210 −0.01550
VLDL particle size, nm 35.99 (1.17) 36.05 (1.30) 0.08900 −0.22600
LDL particle size, nm 23.69 (0.19) 23.69 (0.22) −0.00835 0.01040
HDL particle size, nm 10.08 (0.21) 10.02 (0.24) −5.12E−04 0.03430
IDL cholesterol, mmol/L 0.62 (0.18) 0.57 (0.16) −0.02982 −0.03601
VLDL cholesterol, mmol/L 0.54 (0.20) 0.50 (0.21) −0.01391 −0.03919
Remnant cholesterol, mmol/L 1.61 (0.37) 1.08 (0.37) −0.04792 −0.06558
Glucose, mmol/L 3.90 (0.38) 4.00 (0.42) −0.01730 −0.03610
Lactate, mmol/L 1.34 (0.37) 1.39 (0.39) −0.00507 −0.04630
Pyruvate, mmol/L 0.06 (0.02) 0.06 (0.02) 0.00117 −0.00214
Citrate, mmol/L 0.10 (0.02) 0.10 (0.02) −8.24E−04 −0.00159
Glycerol, mmol/L 0.07 (0.03) 0.07 (0.02) 1.68E−05 −0.00485
Alanine, mmol/L 0.34 (0.06) 0.33 (0.06) 0.00524 −0.00281
Glutamine, mmol/L 0.50 (0.07) 0.51 (0.08) 0.01320 0.01150
Glycine, mmol/L 0.25 (0.05) 0.25 (0.04) 0.00480 0.00263
Histidine, mmol/L 0.06 (0.01) 0.06 (0.01) −6.09E−04 3.70E−04
Isoleucine, mmol/L 0.05 (0.01) 0.05 (0.01) 6.71E−04 −0.00150
Leucine, mmol/L 0.07 (0.01) 0.08 (0.01) 2.44E−04 −0.00138
Valine, mmol/L 0.17 (0.03) 0.18 (0.03) −8.07E−04 −0.00263
Phenylalanine, mmol/L 0.07 (0.01) 0.06 (0.01) −3.05E−04 −5.54E−04
Tyrosine, mmol/L 0.05 (0.01) 0.05 (0.01) −6.60E−04 −9.46E−04
log acetate, mmol/L 0.04 (0.01) 0.04 (0.01) −8.58E−07 5.34E−04
log acetoacetate, mmol/L 0.05 (0.05) 0.06 (0.05) 0.00194 −8.31E−05
log 3-hydroxybutyrate, mmol/L 0.11 (0.08) 0.11 (0.07) 0.00193 −0.00363
Creatinine, mmol/L 0.04 (0.01) 0.05 (0.01) −1.98E−04 −1.54E−04
log albumin, cu 0.09 (0.01) 0.09 (0.01) 3.32E−04 −2.72E−04
Glycoprotein acetyls, mmol/L 1.22 (0.24) 1.19 (0.22) 0.01250 −0.02350
Total phosphoglycerides, mmol/L 1.69 (0.40) 1.54 (0.35) −0.03290 −0.02180
Phosphatidylcholines, mmol/L 1.63 (0.36) 1.50 (0.33) −0.02600 −0.00382
Sphingomyelins, mmol/L 0.41 (0.09) 0.37 (0.09) −0.01580 −0.00387
Mean and SD concentrations of the metabolic measures are from pooled analyses across the 6 time points are shown. A total of 60 metabolic measures were quantified via a high-throughput
serum NMR metabolomics platform.14 Quantification of lipoprotein subclasses was calibrated against high-performance liquid chromatography on an external set of samples. The 14 lipoprotein
subclass sizes were defined as follows: extremely large VLDL with particle diameters from 75 nm upwards and a possible contribution of chylomicrons, 5 VLDL subclasses (average particle di-
ameters of 64.0 nm, 53.6 nm, 44.5 nm, 36.8 nm, and 31.3 nm), IDL (28.6 nm), 3 LDL subclasses (25.5 nm, 23.0 nm, and 18.7 nm), and 4 HDL subclasses (14.3 nm, 12.1 nm, 10.9 nm, and 8.7 nm).
The mean size for VLDL, LDL, and HDL particles was calculated by weighting the corresponding subclass diameters with their particle concentrations.
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Table II. Characteristics of the study participants at 9 and 19 years of age
Characteristics
9 y 19 y
Girls (n = 268) Boys (n = 286) Girls (n = 211) Boys (n = 206)
I Ctl I Ctl I Ctl I Ctl
Height, cm 135.6 (5.9) 135.5 (5.8) 136.0 (5.9) 136.5 (5.3) 167.7 (6.2) 167.1 (6.1) 181.1 (6.6) 181.5 (6.1)
Weight, kg 31.1 (5.5) 31.7 (6.9) 30.6 (5.1) 31.1 (5.2) 62.6 (10.6) 63.4 (12.8) 72.8 (11.4) 75.2 (12.0)
BMI, kg/m2 16.8 (2.1) 17.1 (2.8) 16.5 (1.9) 16.6 (2.2) 22.2 (3.3) 22.7 (4.4) 22.2 (3.0) 22.9 (3.7)
Overweight, % 15.6 22.1 13.1 13.4 9.7 18.6 16.3 22.2
Systolic blood pressure, mm Hg 100.8 (7.7) 100.7 (8.4) 99.8 (6.5) 100.5 (6.5) 116.2 (10.2) 115.1 (12.6) 126.9 (12.1) 129.0 (13.4)
Diastolic blood pressure, mm Hg 57.6 (5.7) 58.2 (6.2) 57.3 (5.7) 58.1 (5.9) 64.9 (6.3) 65.4 (7.7) 65.9 (7.8) 66.3 (8.2)
Dietary energy intake, kcal 1555 (290) 1603 (305) 1729 (296) 1816 (337) 1632 (342) 1606 (411) 2204 (699) 2248 (609)
Dietary fat intake, E% 29.4 (4.6) 32.1 (4.9) 29.9 (4.8) 31.9 (5.3) 31.7 (5.0) 31.5 (6.0) 32.5 (6.2) 32.9 (6.4)
Dietary protein intake, E% 16.6 (2.8) 16.1 (2.5) 16.3 (2.6) 16.1 (2.4) 17.9 (3.2) 17.4 (3.9) 18.9 (3.5) 18.9 (3.6)
Dietary carbohydrate intake, E% 54.0 (4.7) 51.7 (5.2) 53.8 (5.3) 52.0 (5.5) 50.4 (5.6) 49.9 (6.3) 47.8 (6.4) 46.2 (6.8)
Physical activity, MET, h/wk NA NA NA NA 22.1 (22.1) 21.4 (18.4) 30.3 (26.2) 23.7 (22.9)
Smoking, %* NA NA NA NA 10.9 18.1 13.7 23.6
Ctl, control group; I, intervention group; MET, metabolic equivalent; NA, not available.
Data are mean (SD) or percentage.
*Those who smoke at least once a week.
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